taVNS for Recovery After Stroke
EEG Changes and DNA Markers Related to taVNS in Stroke Patients: a Preliminary Study
Recruiting
N/A
Interventional Study
Stroke
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
At a Glance
- Age
- 18 – 80
- Sex
- Any
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 44 (estimated)
- Sponsor
- Casa Colina Hospital and Centers for Healthcare · Other
Who this trial is looking for
This trial is looking for people who have had a stroke within the last month and have motor impairments. Participants will receive either active treatment or a placebo while we measure changes in brain activity and recovery.
Are You a Good Fit for This Trial?
You may be able to join if
- I have had a stroke for the first time.
- It has been less than a month since my stroke.
- I have motor impairments.
You may not be able to join if
- I have advanced heart disease.
- I have advanced lung disease.
- I have advanced liver disease.
- I have advanced kidney disease.
- My resting heart rate is below 60 beats per minute.
- I have confusion or speech difficulties.
- I have other serious neurological problems.
- I have had surgery on my vagus nerve.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your Eligibility
About This Trial
In the United States, more than 795,000 people have a stroke every year. Motor impairment after a stroke is common and can be debilitating. To date, there remain few treatments available to help improve motor recovery after a stroke, making this an important area of research. Novel use of neuromodulation such as Invasive Vagus Nerve Stimulation (VNS) has been shown to improve motor recovery in str…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* First-time Cerebrovascular Accident (Ischemic or Hemorrhagic)
* Within a month post-injury
* Presence of motor impairments (FMA-U≤62)
Exclusion Criteria:
* Advanced cardiac, pulmonary, liver, or kidney disease
* Bradycardia (Resting HR \< 60)
* Presence of Apraxia, Aphasia o…
Contacts